Any systemic treatment vs placebo
Adalimumab · people with chronic plaque psoriasis
Any systemic treatment showed no clear difference in adalimumab compared with placebo (moderate certainty).
2 findings from 1 review
- Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis 2020 · Cochrane Headline outcomes onlyRR 0.98 [0.65, 1.49]10 studies · 3485 participantsModerate
- Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis 2020 · Cochrane Headline outcomes onlyRR 17.82 [14.62, 21.72]9 studies · 3421 participantsModerate